Study | No of patients with HIV | Disease | Viral response | Disease response |
---|---|---|---|---|
Rai et al. 2017 [20] | 11 | 8 Melanoma, 1 HCC, 1 RCC, 1Â BC | No pt. had loss in viral control or immune reconstitution inflammatory syndrome | 2 CR, 1 PR, 4 SD, 4PD |
Heppt et al. 2017 [19] | 10 | Melanoma | No increase in viral load, no effect on CD4 count | Â |
Wightman et al. 2015 [18] | 1 | Melanoma | Improved CD4 count and decrease in Viral load | NA |
Burke et al. 2011 [9] | 1 | Melanoma | Stable CD 4 count and viral load | PR |
Morris et al. 2017 [14] | 2 | Anal cancer | Stable CD4 count and viral load | NA |
Sandoval-Sus et al. 2017 [16] | 1 | Hodgkin lymphoma | Stable CD4 count and viral load | PR |
Tomsitz et al. 2017 [17] | 1 | Melanoma | Stable CD4 count and viral load | PR |
Ruzevick et al. 2013 [15] | 1 | Melanoma | Stable CD4 count and viral load | PR |
Davar et al. 2015 [10] | 1 | Melanoma | Stable CD4 count and viral load | PD |
Le Garff et al. 2017 [12] | 1 | NSCLC | CD4 count increased with stable viral load | PD |
Guihot et al. 2017 [6] | 1 | NSCLC | Stable CD4 count and viral load | PR |
Samri et al. 2017 [7] | 12 | NSCLC | Stable CD4 count and viral load | 3 PR, 4 SD, 5 PD |
Hentrich et al. 2017 [11] | 1 | NSCLC | CD4 count decreased but viral load remained stable | PD |
McCullar et al. 2017 [13] | 1 | NSCLC | CD4 count decreased but viral load remained stable | CR |
Uldrick et al. 2017 (NCT02595866) | 17 | Mix | Increase in CD4 count, viral load remained suppressed | NA |